Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1998
03/17/1998US5728527 Detection of hybridized oligonocleotide probes in living cells
03/17/1998US5728524 Process for categorizing nucleotide sequence populations
03/17/1998US5728523 Polymerase delta mutations in colorectal tumors with replication errors
03/17/1998US5728522 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum
03/17/1998US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
03/17/1998US5728520 Immunoreactive polypeptide compositions
03/17/1998US5728518 Soluble complex of a poly- or oligonucleotide and a carrier
03/17/1998US5728412 Alcohol acetyltransferase genes and use thereof
03/17/1998US5728399 Use of a bacterial component to enhance targeted delivery of polynucleotides to cells
03/17/1998US5728387 Structural gene of pneumococcal protein
03/17/1998US5728382 Fungicidal protein active against dutch elm disease
03/17/1998US5728379 Tumor- or cell-specific herpes simplex virus replication
03/17/1998CA1339758C Human reg protein
03/17/1998CA1339757C Production of purified biologically active, bacterially produced recombinant human csf-1
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339735C Cloning and sequencing of the major outer capsid gylcoprotein gene of a human rotavirus
03/17/1998CA1339734C Bacillus thuringiensis transformation
03/17/1998CA1339733C Cis-acting repression sequences, cis-acting anti-repression sequences vectors, methods of preparation and use
03/17/1998CA1339732C Synthesis and immunogenicity of rotavirus genes using baculovirus expression system
03/17/1998CA1339731C Multiplex genomic dna amplification for deletion detection
03/17/1998CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection
03/17/1998CA1339729C Human papillomavirus type 52 dna sequences and methods for employing thesame
03/17/1998CA1339728C Olignoucleotide probes for dection of peridontal pathogens
03/17/1998CA1339727C Multiplex sequencing
03/13/1998CA2215489A1 Process for amplifying nucleic acids
03/13/1998CA2215084A1 Cytoplasmic male sterility dna factor and utilization thereof
03/12/1998WO1998010515A1 Electroporation employing user-configured pulses
03/12/1998WO1998010291A1 Biochemical markers of the human endometrium
03/12/1998WO1998010287A1 A screening assay for thrombin receptor antagonists
03/12/1998WO1998010273A1 Methods and materials for optimization of electronic hybridization reactions
03/12/1998WO1998010102A2 Multi-resistant bacteria, methods for obtaining them and their uses
03/12/1998WO1998010101A1 Nucleic acid assay for the detection and differentiation of three chlamydia species
03/12/1998WO1998010095A1 Characterising dna
03/12/1998WO1998010090A1 Gata-6 transcription factor: compositions and methods
03/12/1998WO1998010089A1 A method of improving the production of biomass or a desired product from a cell
03/12/1998WO1998010088A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
03/12/1998WO1998010087A1 Chimpanzee adenovirus vectors
03/12/1998WO1998010086A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998WO1998010085A2 Gene therapy for congestive heart failure
03/12/1998WO1998010084A1 Tetracycline transactivator having a nuclear localization signal joined thereto
03/12/1998WO1998010083A1 Herpesvirus saimiri as viral vector
03/12/1998WO1998010082A1 Materials and methods for increasing corn seed weight
03/12/1998WO1998010081A2 Improved barstar-gene
03/12/1998WO1998010080A1 Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein
03/12/1998WO1998010079A1 A lactic acid bacterial regulatable expression system
03/12/1998WO1998010078A2 CLONING OF FULL-LENGTH HUMAN PEX cDNA
03/12/1998WO1998010077A1 System for in vitro transposition using modified tn5 transposase
03/12/1998WO1998010076A2 Phospholipase d and dna sequences
03/12/1998WO1998010075A1 Microorganism, lactamase enzyme obtained therefrom, and their use
03/12/1998WO1998010074A2 Adenylosuccinate synthetase
03/12/1998WO1998010073A1 Material and method for detecting fungi
03/12/1998WO1998010072A1 INTERFERON-η INDUCING FACTOR IN NEUROENDOCRINE CELLS
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998010070A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND
03/12/1998WO1998010069A2 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998010067A1 Human homolog of the latheo gene
03/12/1998WO1998010066A1 Modulators of brca1 activity
03/12/1998WO1998010065A1 Breast carcinoma-associated gene
03/12/1998WO1998010064A1 Iron regulated promoter and uses thereof
03/12/1998WO1998010063A1 Methods for preparing synthetic repetitive dna
03/12/1998WO1998010062A1 Monocot seed gene expression system
03/12/1998WO1998010059A1 Cell-based drug screens for regulators of gene expression
03/12/1998WO1998010058A1 Human cns cell lines and methods of use therefor
03/12/1998WO1998010057A1 Methods for testing compounds for use as therapeutic antioxidants
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009990A1 Fungal antigens and process for producing the same
03/12/1998WO1998009983A2 Preparation of purified (poly)peptides
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009979A1 Lipid metabolic pathway compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009657A2 Method for recombinant adeno-associated virus-directed gene therapy
03/12/1998WO1998009655A1 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009648A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
03/12/1998WO1998009646A1 A method for generating birnavirus from synthetic rna transcripts
03/12/1998WO1998009639A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998WO1998009524A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors
03/12/1998WO1998009521A1 Dna and encoded protein which regulates cold and dehydration regulated genes
03/12/1998WO1998009510A1 Methods of diagnosing and treating cancer
03/12/1998WO1998009505A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998WO1998004712A3 Substrate trapping protein tyrosine phosphatases
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998003662A3 Drosophila melanogaster p70 s6 kinase
03/12/1998WO1998001563A3 Adenovirus e4 proteins for inducing cell death
03/12/1998WO1998001161A3 Gene therapy delivery system for targeting to endothelia
03/12/1998WO1998000552A3 Receptor tyrosine phosphatase, and uses related thereto
03/12/1998WO1998000545A3 G protein signal transduction in plants
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997042326A3 Regulating metabolism by modifying the level of trehalose-6-phosphate
03/12/1998WO1997038087A3 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636917A1 Nucleic acid encoding starch synthase enzymes from wheat
03/12/1998CA2718347A1 Gene therapy for congestive heart failure
03/12/1998CA2639051A1 Fungal antigens and process for producing the same
03/12/1998CA2266190A1 Multi-resistant bacteria, methods for obtaining them and their uses
03/12/1998CA2265895A1 Nucleic acid assay for the detection and differentiation of three chlamydia species